Improvement in quality of life and cardiac function after catheter ablation for asymptomatic persistent atrial fibrillation

Abstract Background Catheter ablation (CA) for atrial fibrillation (AF) is widely performed. However, the indication for CA in patients with asymptomatic persistent AF is still controversial. Methods Among 259 consecutive patients who were hospitalized for initial CA of AF, a total of 45 patients wh...

Full description

Bibliographic Details
Main Authors: Naoaki Onishi, Shokan Kyo, Maki Oi, Toshikazu Jinnai, Maiko Kuroda, Yukiko Shimizu, Sari Imamura, Takeshi Harita, Suguru Nishiuchi, Koji Hanazawa, Toshihiro Tamura, Chisato Izumi, Yoshihisa Nakagawa, Kazuaki Kaitani
Format: Article
Language:English
Published: Wiley 2021-02-01
Series:Journal of Arrhythmia
Subjects:
Online Access:https://doi.org/10.1002/joa3.12457
id doaj-0c075d27b7a2436d928d3d53cef2689b
record_format Article
spelling doaj-0c075d27b7a2436d928d3d53cef2689b2021-03-06T06:11:15ZengWileyJournal of Arrhythmia1880-42761883-21482021-02-01371111910.1002/joa3.12457Improvement in quality of life and cardiac function after catheter ablation for asymptomatic persistent atrial fibrillationNaoaki Onishi0Shokan Kyo1Maki Oi2Toshikazu Jinnai3Maiko Kuroda4Yukiko Shimizu5Sari Imamura6Takeshi Harita7Suguru Nishiuchi8Koji Hanazawa9Toshihiro Tamura10Chisato Izumi11Yoshihisa Nakagawa12Kazuaki Kaitani13Division of Cardiology Tenri Hospital Tenri JapanJapanese Red Cross Otsu Hospital Otsu JapanJapanese Red Cross Otsu Hospital Otsu JapanJapanese Red Cross Otsu Hospital Otsu JapanDivision of Cardiology Tenri Hospital Tenri JapanDivision of Cardiology Tenri Hospital Tenri JapanDivision of Cardiology Tenri Hospital Tenri JapanDivision of Cardiology Tenri Hospital Tenri JapanDivision of Cardiology Tenri Hospital Tenri JapanDivision of Cardiology Tenri Hospital Tenri JapanDivision of Cardiology Tenri Hospital Tenri JapanDivision of Cardiology Tenri Hospital Tenri JapanDivision of Cardiology Tenri Hospital Tenri JapanDivision of Cardiology Tenri Hospital Tenri JapanAbstract Background Catheter ablation (CA) for atrial fibrillation (AF) is widely performed. However, the indication for CA in patients with asymptomatic persistent AF is still controversial. Methods Among 259 consecutive patients who were hospitalized for initial CA of AF, a total of 45 patients who had asymptomatic persistent AF were retrospectively analyzed. Quality of life (QOL) before and 1 year after CA was evaluated, and changes in the cardiac function over 5 years after CA were also examined. QOL was assessed using the AF QOL questionnaire (AFQLQ) developed by the Japanese Heart Rhythm Society. In addition, cardiac function was assessed by measuring the plasma B‐type natriuretic peptide (BNP) level, left ventricular ejection fraction (LVEF), left atrial diameter (LAD) with transthoracic echocardiogram, and left atrial (LA) volume with computed tomography (CT). Results The AFQLQ significantly improved after CA in terms of “symptom frequency” and “activity limits and mental anxiety.” The plasma BNP level, LVEF, and LAD significantly improved in the first 3 months after the first CA, with no significant changes thereafter (from 149.0 pg/dL [95% confidence intervals {CI}, 114.5‐183.5 pg/dL] to 49.8 pg/dL [95% CI, 26.5‐70.1], P < .0001; from 60.8% [95% CI, 58.1%–63.6%] to 65.0% [95% CI, 62.6‐67.4], P = .001; and from 41.3 mm [95% CI, 39.7‐42.9] to 36.8 [95% CI, 34.5‐39.1 mm], P < .0001, respectively). LA volume revealed LA reverse remodeling after CA. Conclusion Improvement in the QOL and cardiac function after CA of asymptomatic persistent AF was revealed. Asymptomatic persistent AF should be appropriately treated by CA.https://doi.org/10.1002/joa3.12457atrial fibrillationB‐type natriuretic peptidecatheter ablationquality of lifereverse remodeling
collection DOAJ
language English
format Article
sources DOAJ
author Naoaki Onishi
Shokan Kyo
Maki Oi
Toshikazu Jinnai
Maiko Kuroda
Yukiko Shimizu
Sari Imamura
Takeshi Harita
Suguru Nishiuchi
Koji Hanazawa
Toshihiro Tamura
Chisato Izumi
Yoshihisa Nakagawa
Kazuaki Kaitani
spellingShingle Naoaki Onishi
Shokan Kyo
Maki Oi
Toshikazu Jinnai
Maiko Kuroda
Yukiko Shimizu
Sari Imamura
Takeshi Harita
Suguru Nishiuchi
Koji Hanazawa
Toshihiro Tamura
Chisato Izumi
Yoshihisa Nakagawa
Kazuaki Kaitani
Improvement in quality of life and cardiac function after catheter ablation for asymptomatic persistent atrial fibrillation
Journal of Arrhythmia
atrial fibrillation
B‐type natriuretic peptide
catheter ablation
quality of life
reverse remodeling
author_facet Naoaki Onishi
Shokan Kyo
Maki Oi
Toshikazu Jinnai
Maiko Kuroda
Yukiko Shimizu
Sari Imamura
Takeshi Harita
Suguru Nishiuchi
Koji Hanazawa
Toshihiro Tamura
Chisato Izumi
Yoshihisa Nakagawa
Kazuaki Kaitani
author_sort Naoaki Onishi
title Improvement in quality of life and cardiac function after catheter ablation for asymptomatic persistent atrial fibrillation
title_short Improvement in quality of life and cardiac function after catheter ablation for asymptomatic persistent atrial fibrillation
title_full Improvement in quality of life and cardiac function after catheter ablation for asymptomatic persistent atrial fibrillation
title_fullStr Improvement in quality of life and cardiac function after catheter ablation for asymptomatic persistent atrial fibrillation
title_full_unstemmed Improvement in quality of life and cardiac function after catheter ablation for asymptomatic persistent atrial fibrillation
title_sort improvement in quality of life and cardiac function after catheter ablation for asymptomatic persistent atrial fibrillation
publisher Wiley
series Journal of Arrhythmia
issn 1880-4276
1883-2148
publishDate 2021-02-01
description Abstract Background Catheter ablation (CA) for atrial fibrillation (AF) is widely performed. However, the indication for CA in patients with asymptomatic persistent AF is still controversial. Methods Among 259 consecutive patients who were hospitalized for initial CA of AF, a total of 45 patients who had asymptomatic persistent AF were retrospectively analyzed. Quality of life (QOL) before and 1 year after CA was evaluated, and changes in the cardiac function over 5 years after CA were also examined. QOL was assessed using the AF QOL questionnaire (AFQLQ) developed by the Japanese Heart Rhythm Society. In addition, cardiac function was assessed by measuring the plasma B‐type natriuretic peptide (BNP) level, left ventricular ejection fraction (LVEF), left atrial diameter (LAD) with transthoracic echocardiogram, and left atrial (LA) volume with computed tomography (CT). Results The AFQLQ significantly improved after CA in terms of “symptom frequency” and “activity limits and mental anxiety.” The plasma BNP level, LVEF, and LAD significantly improved in the first 3 months after the first CA, with no significant changes thereafter (from 149.0 pg/dL [95% confidence intervals {CI}, 114.5‐183.5 pg/dL] to 49.8 pg/dL [95% CI, 26.5‐70.1], P < .0001; from 60.8% [95% CI, 58.1%–63.6%] to 65.0% [95% CI, 62.6‐67.4], P = .001; and from 41.3 mm [95% CI, 39.7‐42.9] to 36.8 [95% CI, 34.5‐39.1 mm], P < .0001, respectively). LA volume revealed LA reverse remodeling after CA. Conclusion Improvement in the QOL and cardiac function after CA of asymptomatic persistent AF was revealed. Asymptomatic persistent AF should be appropriately treated by CA.
topic atrial fibrillation
B‐type natriuretic peptide
catheter ablation
quality of life
reverse remodeling
url https://doi.org/10.1002/joa3.12457
work_keys_str_mv AT naoakionishi improvementinqualityoflifeandcardiacfunctionaftercatheterablationforasymptomaticpersistentatrialfibrillation
AT shokankyo improvementinqualityoflifeandcardiacfunctionaftercatheterablationforasymptomaticpersistentatrialfibrillation
AT makioi improvementinqualityoflifeandcardiacfunctionaftercatheterablationforasymptomaticpersistentatrialfibrillation
AT toshikazujinnai improvementinqualityoflifeandcardiacfunctionaftercatheterablationforasymptomaticpersistentatrialfibrillation
AT maikokuroda improvementinqualityoflifeandcardiacfunctionaftercatheterablationforasymptomaticpersistentatrialfibrillation
AT yukikoshimizu improvementinqualityoflifeandcardiacfunctionaftercatheterablationforasymptomaticpersistentatrialfibrillation
AT sariimamura improvementinqualityoflifeandcardiacfunctionaftercatheterablationforasymptomaticpersistentatrialfibrillation
AT takeshiharita improvementinqualityoflifeandcardiacfunctionaftercatheterablationforasymptomaticpersistentatrialfibrillation
AT sugurunishiuchi improvementinqualityoflifeandcardiacfunctionaftercatheterablationforasymptomaticpersistentatrialfibrillation
AT kojihanazawa improvementinqualityoflifeandcardiacfunctionaftercatheterablationforasymptomaticpersistentatrialfibrillation
AT toshihirotamura improvementinqualityoflifeandcardiacfunctionaftercatheterablationforasymptomaticpersistentatrialfibrillation
AT chisatoizumi improvementinqualityoflifeandcardiacfunctionaftercatheterablationforasymptomaticpersistentatrialfibrillation
AT yoshihisanakagawa improvementinqualityoflifeandcardiacfunctionaftercatheterablationforasymptomaticpersistentatrialfibrillation
AT kazuakikaitani improvementinqualityoflifeandcardiacfunctionaftercatheterablationforasymptomaticpersistentatrialfibrillation
_version_ 1724229812492435456